About Us

As one of the world’s most renowned companies for contract development and manufacturing, Lonza Pharma & Biotech is recognized for our reliable, high-quality services, our global capacity, our innovative technology platforms, and our extensive experience. From 2013 to 2016, our contributions supported 36% of launches with breakthrough designation. In 2016 alone, we provided manufacturing services for more than 50 commercial molecules and conducted more than 250 development programs. We have helped launch pioneering autologous cell therapies.

Success for us is when you, as our partner, are fully satisfied. We continuously improve and innovate to meet your expectations and improve your chances of business success. Our broad capabilities span across biologics, small molecules, bioconjugates, and cell and gene therapies. We manage projects from pre-clinical stage through to commercialization, and our expertise covers both drug substance and drug product.

We believe that the best outcome – for you and for your patients – can only come as a result of a successful collaboration. Together, we can solve the next challenge and bring your next medicine to life.


Cell and Gene Therapy
The field of cell and gene therapy is transforming the way patients, diagnosed with cancers or genetic diseases, can be treated
Learn More
Small Molecules
The small molecule medicine market has entered a transition phase; drug candidates in the development pipeline are increasingly innovative, complex and highly potent specialty medicines
Learn More
In our extensive contract development and manufacturing services portfolio we use advanced technologies to quickly and efficiently deliver products such as monoclonal antibodies, complex proteins and recombinant proteins
Learn More
Using advanced engineering and process development capabilities, we offer customized solutions for the development and manufacture of these molecules
Learn More
Drug Product Services
A holistic phase-appropriate approach to parenteral drug product development and manufacturing that anticipates and prevents problems safe guarding your program’s success
Learn More
Discovery Services
In silico and in vitro services for manufacturability, immunogenicity, humanization, protein engineering and non-GMP production of proteins
Learn More

Lonza acquired Capsugel to create an integrated solutions provider to the global pharma and consumer healthcare industries.

Find Out More

Ibex Solutions offer product lifecycle management and agility for biologics. The offering spans across the preclinical to commercial stage, from drug substance to drug product.

Find Out More

Bioscience Products and Services

Lonza’s Bioscience products, services and testing solutions support researchers through their cell biology process, from early research through drug discovery and cell therapy. We provide the tools to generate decision-driving data quickly and easily. Our products include primary cells as well as cell culture and transfection tools for life-science research, media used in the production of therapeutics and endotoxin detection assays to help assure the safety of injectable drugs.
Visit Our Website

Contact Us

Are you looking for a reliable, experienced, and adaptive partner with expertise in drug substance and drug product? We have the capacity to manage projects from pre-clinical stage to commercialization successfully. Let's meet the next challenge together.

By submitting your data through this form, you confirm that you are above the age of 18, that you have read and understood the Privacy Policy, and that you agree to the collection, use and processing of your Personal Information by Lonza in accordance with said policy.